jones and his cronies must be voted out

Jones's track record "he and his cronies" must be voted out.

i) When he was Chairman of Psiron (now Viralytics) in 2004 at the AGM in November 2004 (share price was $2.30) he boasted of the "Canon Deal" via the company IDAL would receive large royalty payments and in turn Psiron (as a substainial shareholder of IDAL) would received a significant portion of those royalty payments. To date that deal has not eventuated and no royalty payments have been received.

ii) At the same AGM (in November 2004) he introduced his directors and senior staff to the shareholders including Mr Bryan Dulhunty who was BOTH the Finance Director and Company Secretary. The question that needs to be asked with the current senior management structure of Cbio as Executive Chairman he has both a Finance Director and Company Secretary "why????" it appears Jones has no idea about controlling overheads and surrounds himself with his "yes men" and shareholders have paid dearly for that privilege.

iii) When he was Chairman of Psiron (now Viralytics) in 2005 at the AGM in November 2005 stated that the "Company was undervalued and massively so". At that stage the share price was $1.80 (remember it was $2.30 at the same time in the previous year).Jones resigned from the Psiron board on the 10th April 2006 when the price was $1.50.

iv) As Chairman of Cbio at the AGM in November 2005 he stated "CBio is the real thing". The Board is confident that in the next few months we will settle a term sheet with a multi-national. Due to the potential applications of this drug it is not possible to determine the true value of our IP at this point in time. We believe however that a sale value of at least $2 billion dollars could be achieved. We anticipate that the Company will not be in the hands of its current shareholders by the end of next year, or if it is, it will be quite a different corporate body - It is now September 2011 nearly 6 years have passed and the shareholders are still waiting!!!

v) In August 2006 as Chairman of Cbio announced that CBio has just raised $2.5m by the placing of shares to sophisticated and professional investors at $6 per share!!!!!.

He certainly had us all fooled. As a long term shareholder (have had shares since May 2004) I have had enough. Three new directors will add "fresh blood" to the company. I feel Jones is far too close to the "Novo team" and is not acting in the best interest of all the shareholders.